A Single-Dose, Comparative Bioavailability Study of Two Formulations of Divalproex Sodium 125 MG Delayed Release Tablets Under Fasting Conditions.
Phase of Trial: Phase I
Latest Information Update: 31 Mar 2017
At a glance
- Drugs Valproate semisodium (Primary)
- Indications Bipolar disorders; Epilepsy; Migraine
- Focus Pharmacokinetics
- 22 Mar 2009 New trial record